Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$151.44 - $200.09 $182,939 - $241,708
1,208 New
1,208 $238,000
Q1 2023

Apr 17, 2023

SELL
$145.48 - $175.02 $214,292 - $257,804
-1,473 Reduced 38.63%
2,340 $389,000
Q4 2022

Feb 09, 2023

BUY
$131.14 - $157.47 $161,039 - $193,373
1,228 Added 47.5%
3,813 $558,000
Q3 2022

Oct 26, 2022

BUY
$148.29 - $182.55 $383,329 - $471,891
2,585 New
2,585 $383,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.3B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Financial Insights, Inc. Portfolio

Follow Financial Insights, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Insights, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Insights, Inc. with notifications on news.